A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.

Frank Oberpenning; Christoph Weining; Burkhard Brandt; Gabriela De Angelis; Achim Heinecke; Michael Hamm; Petra Stieber; Lothar Hertle; Hans-Peter Schmid; Axel Semjonow

doi:10.1515/CCLM.2003.016

A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.

Identifier:nobleid.org/w1/20260515/BBCD7542

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBCD7542.svg?ark=w1%2F20260515%2FBBCD7542)](https://nobleid.org/work/w1/20260515/BBCD7542)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.

Identifier:nobleid.org/w1/20260515/BBCD7542

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBCD7542.svg?ark=w1%2F20260515%2FBBCD7542)](https://nobleid.org/work/w1/20260515/BBCD7542)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work